Ab Science
Clinical trials sponsored by Ab Science, explained in plain language.
-
Promising ALS drug combo heads to final phase 3 trial
Disease control Not yet recruitingThis phase 3 trial tests whether adding masitinib to standard ALS treatment (riluzole) can slow the loss of physical function better than placebo plus riluzole. About 412 adults with ALS will take the drug or placebo for 48 weeks. The main goal is to measure changes in daily abil…
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New pill hopes to slow Alzheimer's decline
Disease control Not yet recruitingThis phase 3 trial tests whether adding masitinib, a daily pill that targets immune cells in the brain, to standard Alzheimer's medications can slow cognitive and functional decline. The study will enroll 600 people with mild Alzheimer's and measure changes in thinking skills and…
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated May 26, 2026 07:20 UTC